Kestra Advisory Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$168K	Sell	33,165 -9,990	-23%	-$50.5K	﹤0.01%	2672
2025 Q1	$228K	Buy	43,155 +15,153	+54%	+$80.2K	﹤0.01%	2384
2024 Q4	$189K	Buy	+28,002	New	+$189K	﹤0.01%	2488